By Rafael Müller
Publication Date: 2026-10-14 06:50:00
Two separate announcements landed in IBM’s orbit this week — one from a partner, one from a federal research agency — and both point investors toward the same date on the calendar. Fortra rolled out a cyber-resilience service for IBM Power and IBM i environments, while IBM confirmed it had cleared the third phase of DARPA’s Quantum Benchmarking Initiative. Neither development, on its own, settles the question that matters most for the equity: whether IBM can convert its recurring software base back into faster growth.
Fortra’s Continuity Care: A Partner Win, Not Yet an IBM Win
The new offering, branded Continuity Care, leans on FalconStor technology and bundles backup, recoverability verification, and post-incident restoration. Its options are designed to flex with shifting cyber risks and operational demands, targeting the day-to-day running of existing IBM Power and IBM i estates.
For shareholders, the immediate takeaway is limited. A partner’s launch does…
